Back
Danaher Corporation (DHR)
Life Sciences Tools & ServicesDHR · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$215.90
+0.34%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$5.05
ROE
7.1%
Gross margin
59.0%
Debt/Equity
0.37x
Revenue growth
3.7%
Danaher Corporation — company intelligence
Earnings surprises
Q2 2026$1.94 vs $1.85 est+4.7%
Q1 2026$2.06 vs $1.96 est+5.3%
Q4 2025$2.23 vs $2.17 est+2.6%
Q3 2025$1.89 vs $1.74 est+8.7%
Analyst consensus · 32 analysts
27 Buy5 Hold0 Sell
Updated Aug 18, 2026
Insider activity · 90 days
18 buys3 sellsnet +3,572,282 shares
RALES MITCHELL PBuy 500,000 · Aug 4, 2026
RALES MITCHELL PBuy 1,000,000 · Aug 4, 2026
RALES STEVEN MBuy 500,000 · Aug 4, 2026
Recent SEC filings
4 — Insider transaction reportAug 24, 2026
4 — Insider transaction reportAug 6, 2026
4 — Insider transaction reportAug 6, 2026
Latest news
Insider Transaction: Rainer Blair Sells $12.74M Worth Of Danaher Shares — Benzinga · 20h ago
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation? — Yahoo · 4d ago
Danaher (DHR) Jumped, But What Is Drawing Fresh Attention Now? — Yahoo · 6d ago
Danaher (DHR) Stock Looks Fairly Valued On Its 23% Five Year Slide — Yahoo · 6d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.